• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE TAG CONFORMABLE THORACIC STENT GRAFT WITH ACTIVE CONTROL SYSTEM; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE TAG CONFORMABLE THORACIC STENT GRAFT WITH ACTIVE CONTROL SYSTEM; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Model Number TGMR313120
Device Problem Mechanical Problem (1384)
Patient Problem Aortic Dissection (2491)
Event Date 11/04/2020
Event Type  malfunction  
Manufacturer Narrative
Patient medications: not available due to patient being an urgent case.
 
Event Description
On (b)(6) 2020, the patient underwent endovascular treatment for an acute thoracic aortic dissection using a gore® tag® conformable thoracic stent graft with active control system (ctag-ac).It was reported that the ctag-ac device was introduced through a 20fr sheath and placed in the distal thoracic aortic artery above the celiac artery.When the primary deployment handle was pulled back, the suture broke, the physician then attempted to utilize the back up hatch, line number one.The deployment line snapped/broke again.The device was not deployed through these attempts.The device was removed with the delivery catheter through the sheath and will be returned to gore for evaluation.A two different ctag-ac device's were used for the procedure.There was no further issues and no serious injury to the patient.The patient tolerated the procedure.
 
Manufacturer Narrative
Correction h3.Device was returned to manufacturer.Addition the device was returned to gore for evaluation.The gore® tag® conformable thoracic stent graft with active control system (cmds) device evaluation showed the primary deployment line was switched with a steering fiber, such that the primary deployment handle was connected to an angulation fiber, and the primary deployment line (pdl) was connected to the angulation assembly handle.The stent graft of the returned device remained completely constrained.The findings of the evaluation are consistent with the reported event description that primary deployment was unable to be initiated via the primary deployment handle and the deployment line access hatch.The inability to deploy the primary sleeve can be attributed to mis-assembly of the primary deployment handle with an angulation fiber during manufacturing, such that the pdl was not correctly attached to the primary deployment handle.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE TAG CONFORMABLE THORACIC STENT GRAFT WITH ACTIVE CONTROL SYSTEM
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
MDR Report Key10856870
MDR Text Key217673084
Report Number2017233-2020-01451
Device Sequence Number1
Product Code MIH
UDI-Device Identifier00733132646791
UDI-Public00733132646791
Combination Product (y/n)N
PMA/PMN Number
PO40043
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup
Report Date 02/16/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/05/2022
Device Model NumberTGMR313120
Device Catalogue NumberTGMR313120
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 11/04/2020
Initial Date FDA Received11/17/2020
Supplement Dates Manufacturer Received11/04/2020
Supplement Dates FDA Received02/16/2021
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient Age73 YR
Patient Weight86
-
-